Soft Tissue Augmentation (Temporary Injectable Fillers) of the Upper Face (Cheeks, Brow, Forehead, Ear)

  • Sue Ellen CoxEmail author
  • Christie Regula


Facial aging is a multifactorial process that is caused by changes in the skin, fat compartments, and underlying bony elements. Temporary injectable fillers are commonly used to improve the appearance of the aging face by restoring lost volume, smoothing rhytides, reducing skin laxity, and improving facial contouring. These fillers include hyaluronic acid, poly-L-lactic acid, and calcium hydroxyapatite. Filler selection is important for a successful treatment outcome, as is the pre-treatment evaluation, procedure technique, and follow-up care. This chapter specifically reviews the use of temporary injectable fillers for treatment of the upper face including the cheeks, brow, forehead, and ear. A thorough understanding of upper facial anatomy and other specific considerations are important to maintain a good safety profile and obtain excellent results in this region.


Injectable fillers Soft tissue augmentation Filler safety Filler effectiveness Upper face fillers Temporary fillers Soft tissue augmentation 


  1. 1.
    Smith JG, Davidson EA, Clark WM. Alterations in human dermal connective tissue with age and chronic sun damage. J Invest Dermatol. 1962;39:347–56.PubMedGoogle Scholar
  2. 2.
    Berlin AL, Hussain M, Goldberg DJ. Calcium Hydroxylapatite filler for facial rejuvenation: a histologic and immunohistochemical analysis. Dermatol Surg. 2008;34:S64–7.PubMedGoogle Scholar
  3. 3.
    Goldberg D, Guana A, Volk A, Daro-Kaftan E. Single-Arm study for the characterization of human tissue response to injectable Poly-L-Lactic acid. Dermatol Surg. 2013;39(6):915–22.PubMedGoogle Scholar
  4. 4.
    Wang F, Garza L, Kang S, Varani J, Orringer J, Fisher G, Voorhees J. In vivo stimulation of De Novo Collagen production caused by cross-linked Hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermat. 2007;143:155–63.Google Scholar
  5. 5.
    Rohrich R, Pessa J. The fat compartments of the face: anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007;119:2219–27.PubMedGoogle Scholar
  6. 6.
    Gierloff M, Stohring C, Buder T, Gassling V, Acil Y, Wiltfang J. Aging changes of the midfacial fat compartments: a computed tomographic study. Plast Reconstr Surg. 2012;129(1):263–73.PubMedGoogle Scholar
  7. 7.
    Shaw R, Katzel E, Koltz P, Yaremchuk M, Girotto J, Kahn D, Langstein H. Aging of the facial skeleton: aesthetic implications and rejuvenation strategies. Plast Reconstr Surg. 2011;127(1):374–83.PubMedGoogle Scholar
  8. 8.
    Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-Hydroxybu- Tyrate) (PHB), and poly(3-Hydroxybutyrate-Co-3-Hydroxy- Valerate) (PHB/VA). J Biomed Mater Res. 1993;27:1135–48.PubMedGoogle Scholar
  9. 9.
    Marmur E, Phelps R, Goldberg DJ. Clinical, histological and electron microscope findings after injection of a calcium hydroxylapatite filler. J Cosmet Laser Ther. 2004;6:223–6.PubMedGoogle Scholar
  10. 10.
    Narins R, Brandt F, Leyden J, Lorenc P, Rubin M, Smith S. A Randomized, Double-Blind, multicenter comparison of the efficacy and tolerability of restylane versus zyplast collagen for the correction of nasolabial folds. Dermatol Surg. 2003;29:588–95.PubMedGoogle Scholar
  11. 11.
    Berros P. Periorbital contour abnormalities: hollow eye ring management with hyalurostructure. Orbit. 2010;29(2):119–25.PubMedGoogle Scholar
  12. 12.
    Goldberg RA, Fiaschetti D. Filling the periorbital hollows with hyaluronic acid gel: initial experience with 244 injections. Ophthal Plast Reconstr Surg. 2006;22(5):335–43.PubMedGoogle Scholar
  13. 13.
    Kono T, Kinney BM, Groff WF, Chann HH, Ercocen AR, Nozaki M. Randomized, evaluator-blind, split-face comparison study of single cross-linked versus double cross-linked hyaluronic acid in the treatment of glabellar lines. Dermatol Surg. 2008;34(Supl 1):S25–30.PubMedGoogle Scholar
  14. 14.
    Lambros V. A technique for filling the temples with highly diluted hyaluronic acid: the ‘dilution solution. Aesthet Surg J. 2011;31(1):89–94.PubMedGoogle Scholar
  15. 15.
    Moradi A, Shirazi A, Perez A. A guide to temporal fossa augmentation with small gel particle hyaluronic acid dermal filler. J Drugs Dermatol. 2011;10(6):673–6.PubMedGoogle Scholar
  16. 16.
    Morley AM, Malhotra R. Use of hyaluronic acid filler for tear-trough rejuvenation as an alternative to lower eyelid surgery. Ophthal Plast Reconstr Surg. 2011;27(2):69–73.PubMedGoogle Scholar
  17. 17.
    Steinsapir KD, Steinsapir SM. Deep-Fill hyaluronic acid for the temporary treatment of the naso-Jugal groove: a report of 303 consecutive treatments. Ophthal Plast Reconstr Surg. 2006;22(5):344–8.PubMedGoogle Scholar
  18. 18.
    Viana GA, Osaki MH, Cariello AJ, Damasceno RW, Osaki TH. Treatment of the tear trough deformity with hyaluronic acid. Aesthet Surg J. 2011;31(2):225–31.PubMedGoogle Scholar
  19. 19.
    Lindqvist C, Tveten S, Bondevik B, Fagrell D. A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of perlane versus zyplast in the correction of nasolabial folds. Plast Reconstr Surg. 2005;115(1):282–9.PubMedGoogle Scholar
  20. 20.
    Bertucci V, Lin X, Axford-Gatley RA, Theisen MJ, Swift A. Safety and effectiveness of large gel particle hyaluronic acid with lidocaine for correction of midface volume loss. Dermatol Surg. 2013;39:1621–9.PubMedGoogle Scholar
  21. 21.
    Weiss RA, Moragi A, Bank D, Few J, Joseph J, Dover J, Lin X, Nogueira A, Mashburn J. Effectiveness and safety of large gel particle hyaluronic acid with lidocaine for correction of midface volume deficit or contour deficiency. Dermatol Surg. 2016;42:299–709.Google Scholar
  22. 22.
    Morley AM, Taban M, Malhotra R, Goldberg RA. Use of hyaluronic acid gel for upper eyelid filling and contouring. Ophthal Plast Reconstr Surg. 2009;25(6):440–4.PubMedGoogle Scholar
  23. 23.
    Ross JJ, Malhotra R. Orbitofacial rejuvenation of temple hollowing with perlane injectable filler. Aesthet Surg J. 2010;30(3):428–33.PubMedGoogle Scholar
  24. 24.
    Restylane® Silk. [Package insert – clinical trial]. Fort Worth: Galderma Laboratories, L.P; 2016.Google Scholar
  25. 25.
    Bertucci V, Lynde CB. Current concepts in the use of small-particle hyaluronic acid. Plast Reconstr Surg. 2015;136(5 Suppl):132S–8S.PubMedGoogle Scholar
  26. 26.
    Restylane® Refyne. [Package insert – clinical trial]. Fort Worth: Galderma Laboratories, L.P; 2016.Google Scholar
  27. 27.
    Rzany B, Bayerl C, Bodokh I, Boineau D, Dirschka T, Queille-Roussel C, Sebastian M, Sommer B, Edwartz C, Podda M. An 18-Month follow-up, randomized comparison of effectiveness and safety of two hyaluronic acid fillers for treatment of moderate nasolabial folds. Dermatol Surg. 2017;43:58–65.PubMedGoogle Scholar
  28. 28.
    Restylane® Defyne. [Package insert – clinical trial]. Fort Worth: Galderma Laboratories, L.P; 2016.Google Scholar
  29. 29.
    Baumann L, Shamban AT, Lupo MP, Monheit GD, Thomas JA, Murphy DK, Walker PA. Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: a multicenter, double-masked, randomized, within-subject study. Dermatol Surg. 2007;33:S128–35.PubMedGoogle Scholar
  30. 30.
    Lupo MP, Smith SR, Thomas JA, Murphy DK, Beddingfield FC. Effectiveness of juvederm ultra plus dermal filler in the treatment of severe nasolabial folds. Plast Reconstr Surg. 2008;121(1):289–97.PubMedGoogle Scholar
  31. 31.
    Callan P, Goodman GJ, Carlisle I, Liew S, Muzikants P, Scamp T, Halstead M, Rogers JD. Efficacy and safety of a hyaluronic acid filler in subjects treated for correction of midface volume deficiency: a 24 month study. Clin Cosmet Investig Dermatol. 2013;6:81–9.PubMedPubMedCentralGoogle Scholar
  32. 32.
    Jones D, Murphy D. Volumizing hyaluronic acid filler for midface volume deficit: 2-Year results from a pivotal single-blind randomized controlled study. Dermatol Surg. 2013;39:1602–12.PubMedGoogle Scholar
  33. 33.
    Carruthers J, Carruthers A. Three-dimensional forehead reflation. Dermatol Surg. 2015;41:S321–4.PubMedGoogle Scholar
  34. 34.
    Eccleston D, Murphy DK. Juvederm volbella in the perioral area: a 12-month prospective, multicenter, open-label study. Clin Cosmet Invest Dermatol. 2012;5:167–72.Google Scholar
  35. 35.
    Narins RS, Colleman IIIW, Donofrio L, Jones DH, Maas C, Monheit G, Kaur M, Grundy SL, Parrert EJ, Hardas B. Non-animal sourced HA-based dermal filler utilizing a cohesive polydensified matrix technology is superior to bovine collagen in the correction of moderate to severe nasolabial folds: results from a 6-Month, randomized, blinded, controlled, multicenter study. Dermatol Surg. 2010;36:730–40.Google Scholar
  36. 36.
    Narins RS, Colleman IIIW, Donofrio LM, Jones DH, Maas C, Monheit G, Kaur M, Grundy SL, Pappert EJ, Hardas B. Improvement in nasolabial folds with a hyaluronic acid filler using a cohesive polydensified matrix technology: results from an 18-month open-label extension trial. Dermatol Surg. 2010;36:1800–8.PubMedGoogle Scholar
  37. 37.
    Hevia O, Cohen BH, Howell DJ. Safety and efficacy of a cohesive polydensified matrix hyaluronic acid for the correction of infraorbital hollow: an observational study with results at 40 weeks. J Drugs Dermatol. 2014;13(9):1030–6.PubMedGoogle Scholar
  38. 38.
    Burgess CM, Quiroga RM. Assessment of the safety and efficacy of Poly-L-Lactic acid for the treatment of HIV-associated facial lipoatrophy. J Am Acad Dermatol. 2005;52:233–9.PubMedGoogle Scholar
  39. 39.
    Levy RM, Redbord KP, Hanke CW. Treatment of HIV lipoatrophy and lipoatrophy of aging with Poly-L-Lactic Acid: a prospective 3-Year follow-up study. J Am Acad Dermatol. 2008;59:923–33.PubMedGoogle Scholar
  40. 40.
    Narins RS, Baumann L, Brandt FS, Fagien S, Glazer S, Lowe NJ, Monheit GD, Rendon MI, Rohrich RJ, Werschler WP. A randomized study of the efficacy and safety of injectable Poly-L-Lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinkles. J Am Acad Dermatol. 2010;62(3):448–62.PubMedGoogle Scholar
  41. 41.
    Salles AG, Lotierzo PH, Gimenez R, Camargo CP, Ferreira MC. Evaluation of the Poly-L-Lactic Acid implant for treatment of the nasolabial fold: 3-Year follow-up evaluatoin. Aesthet Plast Surg. 2008;32(5):753–6.Google Scholar
  42. 42.
    Palm MD, Woodhall KE, Butterwick KJ, Goldman KP. Cosmetic use of Poly-L-Lactic Acid: a retrospective study of 130 patients. Dermatol Surg. 2010;36:161–70.PubMedGoogle Scholar
  43. 43.
    Sapra S, Stewart JA, Mraud K, Schupp R. A canadian study of the use of Poly-L-Lactic Acid dermal implant for the treatment of hill and valley acne scarring. Dermatol Surg. 2015;41:587–94.PubMedGoogle Scholar
  44. 44.
    Silvers SL, Eviatar JA, Echavez MI, Pappas AL. Prospective, open-Label, 18-Month trial of calcium hydroxylapatite (radiesse) for facial soft-tissue augmenation in patients with human immunodeficiency virus-associated lipoatrophy: one-year durability. Plast Reconstr Surg. 2006;118(3 Suppl):34S–45S.PubMedGoogle Scholar
  45. 45.
    Smith S, Busso M, McClaren M, Bass L. A randomized, bilateral, prospective comparison of calcium hydroxylapatite microspheres versus human-based collagen for the correction of nasolabial folds. Dermatol Surg. 2007;33:S112–21.PubMedGoogle Scholar
  46. 46.
    Ramzi AA, Kassim M, George JV, et al. Dental procedures: is it a risk factor for injectable dermal fillers. Maxillofac Oral Surg. 2015;14(suppl. 01):158–60.Google Scholar
  47. 47.
    Marusza W, Mlynarczyk G, Olszanski R, et al. Probable biofilm formation in the cheek as a complication of soft tissue filler resulting from improper endodontic treatment of tooth 16. Int J Nanomedicine. 2012;7:1441–7.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Dinehart SM, Henry L. Dietary supplements: altered coagulation and effects on bruising. Dermatol Surg. 2005;31(7 Pt 2):819–26. discussion 826Google Scholar
  49. 49.
    Kasuda S, Sakuri Y, Shima M, et al. Inhibition of par4 signaling mediates ethanol-induced attenuation of platlet function in vitro. Alcohol Clin Exp Res. 2006;30(9):1608–14.PubMedGoogle Scholar
  50. 50.
    Otely CC. Perioperative evaluation and management in dermatologic surgery. J Am Acad Dermatol. 2006;54(1):119–27.Google Scholar
  51. 51.
    Seeley BM, Denton AB, Ahn MS, et al. Effect of homeopathic Arnica Montana on bruising in face-lifts: results of a randomized, double blind, placebo-controlled clinical trial. Arch Facial Plastic Surg. 2006;8(1):54–9.Google Scholar
  52. 52.
    Seltzer AP. Minimizing post-operative edema and ecchymoses by the use of an oral enzyme preparation (bromelain). A controlled study of 53 Rhinoplasty cases. Eye Ear Nose Throat Mon. 1962;41:813–7.PubMedGoogle Scholar
  53. 53.
    Sha NS, Lazarus MC, Bugdodel R, et al. The effects of topical vitamine K on bruising after laser treatment. J Am Acad Dermatol. 2004;50(6):982–3.Google Scholar
  54. 54.
    Rzany B, DeLorenzi C. Understanding, avoiding, and managing severe filler complications. Plast Reconstr Surg. 2015;136(5 Suppl):196S–203S.PubMedGoogle Scholar
  55. 55.
    Beer K, Avelar R. Relationship between delayed reactions to dermal fillers and biofilms: facts and considerations. Dermatol Surg. 2014;40(11):1175–9.PubMedGoogle Scholar
  56. 56.
    Mangram AJ, Horan TC, Pearson ML, et al. Guidelines for prevention of surgical site infection. Am J of Infectious Disease. 1999;27(2):97–132.Google Scholar
  57. 57.
    Darouiche RO, Wall MJ Jr, et al. Chlorhexidine-Alcohol versus povidone-Iodine for surgical-site antisepsis. N Engl J Med. 2010;362(1):18–26.Google Scholar
  58. 58.
    Sigorini M, Liew S, Sundaram H. Global aesthetics consensus: avoidance and management of complications from hyaluronic acid fillers-evidence- and opinion-based review and consensus recommendations. Plast Reconstr Surg. 2016;137(6):961e–71e. Scholar
  59. 59.
    Rodriguez J, Xie Y, Winthrop K, Schafer S, et al. Mycobacterium chelonae facial infections following injection of dermal filler. Aesthet Surg J. 2013;33:265–9.PubMedPubMedCentralGoogle Scholar
  60. 60.
    Smith JG, Davidson EA, Clark WM. Alterations in human dermal connective tissue with age and chronic sun damage. J Invest Dermatol. 1962;39:347–56.PubMedGoogle Scholar
  61. 61.
    Pessa JE, et al. Relative maxillary retrusion as a natural consequence of aging. Plast Reconstr Surg. 1998;102:205–12.PubMedGoogle Scholar
  62. 62.
    Woodward J. Review of periorbital and upper face: pertinent anatomy, aging, injection techniques, prevention, and management of complications of facial fillers. J Drugs Dermatol. 2016;15(12):1524–31.PubMedGoogle Scholar
  63. 63.
    Looi AL, Yong KL. Walk the rim, feel the bone’ technique in superior sulcus filling. Plast Reconstr Surg Glop Open. 2016;3(12):592.Google Scholar
  64. 64.
    Langelier N, Beleznay K, Woodward J. Rejuvenation of the upper face and periocular region: combining neuromodulator, facial filler, laser, light, and energy-based therapies for optimal... - PubMed - NCBI. Dermatol Sugery. 2016;42:S77–82.Google Scholar
  65. 65.
    Jung W, Youn KH, Won DY, Park JT, Hu KS, Kim HK. Clinical implications of the middle temporal vein with regard to temporal fossa augmentation. Dermatol Surg. 2014;40(6):618–23.PubMedGoogle Scholar
  66. 66.
    Carey WB, McDevitt SC. Retraction of the plunger on a syringe of hyaluronic acid before injection: are we safe? Dermatol Sugery. 2015;41(Suppl 1):340–6.Google Scholar
  67. 67.
    de Maio M, Rzany B. Injectable fillers in aesthetic medicine. 2nd ed. Berlin: Springer; 2014.Google Scholar
  68. 68.
    Swift S, Remington K. Beautification: a global approach to facial beauty. Clin Plastic Surg. 2011;38:347–77. ElsevierGoogle Scholar
  69. 69.
    Carruthers J, Carruthers A. Volumizing the glabella and forehead. Dermatol Surg. 2010;36:1905–9.PubMedGoogle Scholar
  70. 70.
    Sattler G. Tower technique of filler injections. In: Procedures in cosmetic dermatology. Soft tissue augmentation. 3rd ed. Elsevier: New York; 2013.Google Scholar
  71. 71.
    Glogau RG, Kane MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg. 2008;34(Suppl 1):S 105–9.Google Scholar
  72. 72.
    Rohrich RJ, Nguyen AT, Kenkel JM. Lexicon for soft tissue implants. Dermatol Surg. 2009;35(suppl. 02):1605–11.PubMedGoogle Scholar
  73. 73.
    Fitzgerald R, Bertucci V, Sykes J, Duplechain K. Adverse reactions to injectable fillers. JAMA Facial Plast Surg. 2016;32(5):532–55.Google Scholar
  74. 74.
    Daines S, Williams E. Complications associated with injectable soft-tissue fillersA 5-Year retrospective review. JAMA Facial Plast Surg. 2013;15(3):226–31. Scholar
  75. 75.
    Beleznay K, Carruthers JD, Carruthers A. Delayed-Onset nodules secondary to a smooth cohesive 20mg/Ml hyaluronic acid filler: cause and management. Dermatol Surg. 2015;41(8):929–39.PubMedGoogle Scholar
  76. 76.
    Beleznay K, Humphrey S, Carruthers JD, Carruthers A. Vascular comprimise from soft tissue augmentation: experience with 12 cases and recommendations for optimal outcomes. J Clin Aesthet Dermatol. 2014;7(9):37–43.PubMedPubMedCentralGoogle Scholar
  77. 77.
    Alam M, Kakar R, Nodzenski M. Multicenter prospective cohort study of the incidence of adverse events associated with cosmetic dermatologic procedures lasers, energy devices, and injectable neurotoxins and fillers. JAMA Dermatology. 2015;3:271–7. Scholar
  78. 78.
    Cox SE, Lawrence N. Soft tissue augmentation, Procedures in cosmetic dermatology. 2nd ed. Philadelphia: Saunders, Elsevier; 2008.Google Scholar
  79. 79.
    Yeh LC, Fabi SG, Welsh K. Arterial penetration with blunt-tipped cannulas using injectables: a false sense of safety? Dermatol Surg. 2017;0:1–4.Google Scholar
  80. 80.
    Carruthers J, Fagien S, Rohrich R, Weinkle S, Carruthers A. Blindness caused by cosmetic filler injection: a review of cause and therapy. Plast Reconstr Surg. 2014;134(6):1197–201.PubMedGoogle Scholar
  81. 81.
    Ko E, Kim H, Park W, Kim B. Correction of midface volume deficiency using hyaluronic acid filler and intradermal radiofrequency. J Cosmet Laser Ther. 2015;17:46–8.PubMedGoogle Scholar
  82. 82.
    Goldman M, Alster T, Weiss R. A randomized trial to determine the influence of laser therapy, monopolar radiofrequency treatment, and intense pulsed light therapy administered immediately after hyaluronic acid gel implantation. Dermatol Surg. 2007;33:535–42.PubMedGoogle Scholar
  83. 83.
    Fabi S, Goldman M. The safety and efficacy of combining Poly-L-Lactic Acid with intense pulsed light in facial rejuvenation: a retrospective study of 90 patients. Dermatol Surg. 2012;38:1208–16.PubMedGoogle Scholar
  84. 84.
    Langeilier N, Belezany K, Woodward J. Rejuvenation of the upper face and periocular region: combining neuromodulator, facial filler, laser, light, and energy-based therapies for optimal results. Dermatol Surg. 2016;42:S77–82.Google Scholar
  85. 85.
    Farkas JP, Richardson JA, Brown S, Hoopman JE, et al. Effects of common laser treatments on hyaluronic acid fillers in a porcine model. Aesthet Surg J. 2008;28:503–11.PubMedGoogle Scholar
  86. 86.
    Ramey NA, Woodward JA. Mechanisms of blepharoptosis following cosmetic glabellar chemodenervation. Plast Reconstr Surg. 2010;126:248e–9e.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Aesthetic Solutions, PAChapel HillUSA
  2. 2.Department of DermatologyDuke University School of MedicineDurhamUSA
  3. 3.Vujevich Dermatology AssociatesPittsburghUSA

Personalised recommendations